Log In
Print this Print this

Quadrivalent seasonal influenza VLP vaccine

  Manage Alerts
Collapse Summary General Information
Company Novavax Inc.
DescriptionQuadrivalent virus-like particle (VLP) vaccine containing 2 strains of type A (H1N1 and H3N2) and 2 strains of type B (1 each from Yamagata and Victoria lineages)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today